Recalibration of a Deep Learning Model for Low-Dose Computed Tomographic Images to Inform Lung Cancer Screening Intervals
JAMA Network Open · 16.03.2023 · 6 (3) · e233273
DOI: 10.1001/jamanetworkopen.2023.3273 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 16.03.2023. Verfasst von Rebecca Landy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Beth…. Hauptthemen laut MEDLINE: Lung Neoplasms, Deep Learning. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: World Health Organization, NCI NIH HHS.
Abstract (Originalsprache)
Importance Annual low-dose computed tomographic (LDCT) screening reduces lung cancer mortality, but harms could be reduced and cost-effectiveness improved by reusing the LDCT image in conjunction with deep learning or statistical models to identify low-risk individuals for biennial screening.
Objective
To identify low-risk individuals in the National Lung Screening Trial (NLST) and estimate, had they been assigned a biennial screening, how many lung cancers would have been delayed 1 year in diagnosis. Design, Setting, and Participants This diagnostic study included participants with a presumed nonmalignant lung nodule in the NLST between January 1, 2002, and December 31, 2004, with follow-up completed on December 31, 2009. Data were analyzed for this study from September 11, 2019, to March 15, 2022. Exposures An externally validated deep learning algorithm that predicts malignancy in current lung nodules using LDCT images (Lung Cancer Prediction Convolutional Neural Network [LCP-CNN]; Optellum Ltd) was recalibrated to predict 1-year lung cancer detection by LDCT for presumed nonmalignant nodules. Individuals with presumed nonmalignant lung nodules were hypothetically assigned annual vs biennial screening based on the recalibrated LCP-CNN model, Lung Cancer Risk Assessment Tool (LCRAT + CT [a statistical model combining individual risk factors and LDCT image features]), and the American College of Radiology recommendations for lung nodules, version 1.1 (Lung-RADS). Main Outcomes and Measures Primary outcomes included model prediction performance, the absolute risk of a 1-year delay in cancer diagnosis, and the proportion of people without lung cancer assigned a biennial screening interval vs the proportion of cancer diagnoses delayed.
Results
The study included 10 831 LDCT images from patients with presumed nonmalignant lung nodules (58.7% men; mean [SD] age, 61.9 [5.0] years), of whom 195 were diagnosed with lung cancer from the subsequent screen. The recalibrated LCP-CNN had substantially higher area under the curve (0.87) than LCRAT + CT (0.79) or Lung-RADS (0.69) to predict 1-year lung cancer risk ( P < .001). If 66% of screens with nodules were assigned to biennial screening, the absolute risk of a 1-year delay in cancer diagnosis would have been lower for recalibrated LCP-CNN (0.28%) than LCRAT + CT (0.60%; P = .001) or Lung-RADS (0.97%; P < .001). To delay only 10% of cancer diagnoses at 1 year, more people would have been safely assigned biennial screening under LCP-CNN than LCRAT + CT (66.4% vs 40.3%; P < .001). Conclusions and Relevance In this diagnostic study evaluating models of lung cancer risk, a recalibrated deep learning algorithm was most predictive of 1-year lung cancer risk and had least risk of 1-year delay in cancer diagnosis among people assigned biennial screening. Deep learning algorithms could prioritize people for workup of suspicious nodules and decrease screening intensity for people with low-risk nodules, which may be vital for implementation in health care systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland.
- School of Medicine, Nottingham University Hospitals and the University of Nottingham, Nottingham, United Kingdom.
- Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland.
- Genomic Epidemiology Group, International Agency for Research on Cancer, Lyon, France.
Förderung
- World Health Organization
- NCI NIH HHS
Zitieren
APA
Landy, R., Wang, V. L., Baldwin, D. R., Pinsky, P. F., Cheung, L. C., Castle, P. E., Skarzynski, M., Robbins, H. A., & Katki, H. A. (2023). Recalibration of a Deep Learning Model for Low-Dose Computed Tomographic Images to Inform Lung Cancer Screening Intervals. JAMA Network Open, 6(3), e233273. https://doi.org/10.1001/jamanetworkopen.2023.3273
Vancouver
Landy R, Wang VL, Baldwin DR, Pinsky PF, Cheung LC, Castle PE, et al. Recalibration of a Deep Learning Model for Low-Dose Computed Tomographic Images to Inform Lung Cancer Screening Intervals. JAMA Network Open. 2023;6(3):e233273. doi:10.1001/jamanetworkopen.2023.3273
BibTeX
@article{Landy2023,
author = {Landy, Rebecca and Wang, Vivian L and Baldwin, David R and Pinsky, Paul F and Cheung, Li C and Castle, Philip E and Skarzynski, Martin and Robbins, Hilary A and Katki, Hormuzd A},
title = {Recalibration of a Deep Learning Model for Low-Dose Computed Tomographic Images to Inform Lung Cancer Screening Intervals},
journal = {JAMA Network Open},
year = {2023},
volume = {6},
number = {3},
pages = {e233273},
doi = {10.1001/jamanetworkopen.2023.3273}
}
EUVIMED